<?xml version="1.0" encoding="UTF-8"?>
<table-wrap position="float" id="tbl1">
 <label>Table 1</label>
 <caption>
  <p>Agents\Drugs recommended in the Guidelines (version 7) by the National Health Commission &amp; State Administration of Traditional Chinese Medicine for treatment of COVID-19.</p>
 </caption>
 <alt-text id="alttext0015">Table 1</alt-text>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th>Agent</th>
    <th>Dosage</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td align="left">
     <bold>IFN-α</bold>
    </td>
    <td align="left">5 million U, twice a day.</td>
   </tr>
   <tr>
    <td align="left">
     <bold>Lopinavir/Ritonavir</bold>
    </td>
    <td align="left">200 mg/50 mg per pill for adults, two pills each time, twice a day, no longer than ten days.</td>
   </tr>
   <tr>
    <td align="left">
     <bold>Ribavirin</bold>
    </td>
    <td align="left">500 mg intravenous injection for adults, 2–3 times per day, suggested being used jointly with IFN-α or lopinavir/ritonavir, no longer than ten days.</td>
   </tr>
   <tr>
    <td align="left">
     <bold>Chloroquine phosphate</bold>
    </td>
    <td align="left">500 mg twice a day for a week for adults over 50 kg of body weight.
     <break/>500 mg twice a day for the first and second day and 500 mg once a day for days 3–7 for adults with body weight below 50 kg.
    </td>
   </tr>
   <tr>
    <td align="left">
     <bold>Arbidol</bold>
    </td>
    <td align="left">200 mg three times per day for adults, no longer than ten days.</td>
   </tr>
   <tr>
    <td align="left">
     <bold>Tocilizumab</bold>
    </td>
    <td align="left">4–8 mg/kg (initial dose).
     <break/>400 mg (recommended dose, infusion rate 1.66 ml/min) diluted with 0.9% normal saline to final makeup of 100 ml, not more than 2 infusions.
    </td>
   </tr>
  </tbody>
 </table>
</table-wrap>
